Compare · ASTC vs WAT
ASTC vs WAT
Side-by-side comparison of Astrotech Corporation (DE) (ASTC) and Waters Corporation (WAT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ASTC and WAT operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
- WAT is the larger of the two at $43.64B, about 4177.0x ASTC ($10.4M).
- Over the past year, ASTC is up 8.4% and WAT is up 30.6% - WAT leads by 22.2 points.
- ASTC has been more active in the news (10 items in the past 4 weeks vs 4 for WAT).
- WAT has more recent analyst coverage (25 ratings vs 0 for ASTC).
- Company
- Astrotech Corporation (DE)
- Waters Corporation
- Price
- $4.79-7.09%
- $436.95-1.63%
- Market cap
- $10.4M
- $43.64B
- 1M return
- -23.87%
- +1.57%
- 1Y return
- +8.38%
- +30.56%
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 1995
- News (4w)
- 10
- 4
- Recent ratings
- 0
- 25
Astrotech Corporation (DE)
Astrotech Corporation operates as a science and technology development and commercialization company worldwide. It operates through three segments, Astrotech Technologies, Inc. (ATI), 1st Detect Corporation (1st Detect), and AgLAB Inc (AgLAB). The ATI segment owns and licenses the AMS Technology, the platform mass spectrometry technology. The 1st Detect segment manufactures explosives and narcotics trace detectors for use at airports, secured facilities, and borders. This segment provides TRACER 1000, a mass spectrometer based explosives trace detector to replace the explosives trace detectors used at airports, cargo and secured facilities, and borders. The AgLAB segment develops AgLAB-1000, a mass spectrometer for use in the hemp and cannabis market. It also develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. Astrotech Corporation was incorporated in 1984 is based in Austin, Texas.
Waters Corporation
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company has a collaboration with Genovis AB to develop and market biopharmaceutical characterization workflows based on the its BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
Latest ASTC
- Director Kreps Matthew was granted 1,114 shares, increasing direct ownership by 52% to 3,264 units (SEC Form 4)
- Director Winn Charles Arch was granted 1,331 shares, increasing direct ownership by 10% to 14,431 units (SEC Form 4)
- Director Halinski John William was granted 1,331 shares, increasing direct ownership by 11% to 13,542 units (SEC Form 4)
- Director Stober Eric was granted 1,473 shares, increasing direct ownership by 7% to 21,127 units (SEC Form 4)
- Director Mcfarland Robert N was granted 1,331 shares, increasing direct ownership by 6% to 22,292 units (SEC Form 4)
- Director Wilkinson Tom was granted 1,331 shares, increasing direct ownership by 4% to 32,254 units (SEC Form 4)
- SEC Form 10-K filed by Astrotech Corporation (DE)
- Astrotech Corporation (DE) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Astrotech Reports Fiscal Year 2026 Financial Results
- Innventure Leadership Increases Focus on Accelsius Value Creation, Implements Significant Cost Cuts, and Strengthens Board Independence
Latest WAT
- Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release
- Director Knight Heather was granted 57 shares, increasing direct ownership by 4% to 1,338 units (SEC Form 4)
- Director Jiang Wei was granted 57 shares, increasing direct ownership by 2% to 3,630 units (SEC Form 4)
- Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call
- Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer
- Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference
- UBS resumed coverage on Waters with a new price target
- SEC Form 3 filed by new insider Wu Tong (Nmn)
- Waters upgraded by Piper Sandler with a new price target
- Waters Corporation to Present at the Wells Fargo Healthcare Conference